The in vitro fertilization (IVF) market is poised for substantial growth, with an estimated value of USD 819.8 million by 2024. Analysts predict a strong compound annual growth rate (CAGR) of 9% from 2024 to 2034, reaching a valuation of USD 1,940.8 million by 2034. This growth is largely fueled by the increasing prevalence of infertility globally, leading to a higher demand for effective and accessible IVF treatments.
As more couples turn to assisted reproductive technologies to overcome infertility challenges, the importance of IVF in addressing reproductive issues is becoming more prominent. The market expansion reflects the advancements in reproductive medicine and the growing need for innovative solutions to help individuals achieve their dream of parenthood.
Currently, the IVF sector dominates the infertility treatment market worldwide. The rise in demand for IVF procedures, coupled with the increased accessibility to fertility treatments through the establishment of more IVF clinics and hospitals, is driving this dominance. The advantages of IVF, including higher success rates, are becoming more widely recognized, further contributing to market growth.
Key takeaways from the report include the expected surge in demand for egg banking services, with Europe leading the IVF banking services market. Latin America is also projected to emerge as a lucrative market for IVF banking services in the coming years. Additionally, the rising demand for andrology services and fresh donor egg cycle services will drive growth in the market.
Advanced IVF techniques such as genetic diagnosis, three-parent IVF, and percutaneous epididymal sperm aspiration are revolutionizing the field of reproductive medicine. The increasing awareness among patients and their willingness to invest in advanced treatment procedures are creating lucrative growth opportunities for the market.
The global IVF industry is highly competitive, with numerous regional and local firms vying for market share. Leading companies are focusing on expanding their product offerings and services through partnerships, mergers, acquisitions, and collaborations to stay competitive in the market. For instance, Hamilton Thorne Ltd., Ro, and Fujifilm Irvine Scientific, Inc. have all made strategic moves to enhance their positions in the IVF market.
Key companies in the IVF market include Vitrolife, Thermo Fisher Scientific Inc, Cook Group, and Fujifilm Irvine Scientific, among others. The market is segmented by product, cycle, end user, and type, with different regions such as North America, Europe, Asia Pacific, and Latin America experiencing varying levels of growth.
Future Market Insights (FMI) provides comprehensive insights into the factors driving demand in the market, offering market intelligence, advisory services, consulting, and events across various industries. With a global team of over 400 analysts, FMI delivers expertise on industry trends and market dynamics in more than 110 countries worldwide.